JP2005507944A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005507944A5 JP2005507944A5 JP2003541742A JP2003541742A JP2005507944A5 JP 2005507944 A5 JP2005507944 A5 JP 2005507944A5 JP 2003541742 A JP2003541742 A JP 2003541742A JP 2003541742 A JP2003541742 A JP 2003541742A JP 2005507944 A5 JP2005507944 A5 JP 2005507944A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- rna
- ribonucleoside
- analogue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0126701A GB0126701D0 (en) | 2001-11-07 | 2001-11-07 | Improvements in or relating to induction of mutations in viruses |
| US10/207,005 US7049303B2 (en) | 2001-11-07 | 2002-07-30 | Inhibition of viruses |
| PCT/GB2002/005031 WO2003039450A2 (en) | 2001-11-07 | 2002-11-07 | Improvements in or relating to inhibition of viruses |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005507944A JP2005507944A (ja) | 2005-03-24 |
| JP2005507944A5 true JP2005507944A5 (https=) | 2006-01-12 |
Family
ID=26246745
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003541742A Withdrawn JP2005507944A (ja) | 2001-11-07 | 2002-11-07 | ウイルスの抑制における改善およびその関連 |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US7049303B2 (https=) |
| EP (1) | EP1441744A2 (https=) |
| JP (1) | JP2005507944A (https=) |
| AU (1) | AU2002337388A1 (https=) |
| WO (1) | WO2003039450A2 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7094768B2 (en) * | 2002-09-30 | 2006-08-22 | Genelabs Technologies, Inc. | Nucleoside derivatives for treating hepatitis C virus infection |
| AU2003279797B2 (en) * | 2002-09-30 | 2009-10-22 | Genelabs Technologies, Inc. | Nucleoside derivatives for treating hepatitis C virus infection |
| EP1682564A1 (en) * | 2003-10-27 | 2006-07-26 | Genelabs Technologies, Inc. | METHODS FOR PREPARING 7-(2 -SUBSTITUTED-s-D-RIBOFURANO SYL)-4-(NR2R3)-5-(SUBSTITUTED ETHYN-1-YL)-PYRROLO 2,3-D|PYRIMIDINE DERIVATIVES |
| KR101170925B1 (ko) | 2004-06-18 | 2012-08-07 | 노바티스 백신즈 앤드 다이아그노스틱스 인코포레이티드 | 암 치료용 키네신 방추 단백질 (ｋｓｐ) 억제제로서의ｎ-(1-(1-벤질-4-페닐-1ｈ-이미다졸-2-일)-2,2-디메틸프로필)벤자미드 유도체 및 관련 화합물 |
| EP1858889A1 (en) * | 2005-03-08 | 2007-11-28 | Biota Scientific Management Pty. Ltd. | Bicyclic nucleosides and nucleotides as therapeutic agents |
| US8415321B2 (en) | 2008-04-15 | 2013-04-09 | Raymond F. Schinazi | Nucleoside derivatives for treatment of Caliciviridae infections, including Norovirus infections |
| ES2540964T3 (es) | 2009-06-08 | 2015-07-15 | Takeda Pharmaceutical Company Limited | Compuestos de dihidropirrolonaftiridinona como inhibidores de JAK |
| BR112015009636A8 (pt) * | 2012-10-29 | 2018-04-17 | Cocrystal Pharma Inc | composto, métodos para o tratamento de um hospedeiro infectado, métodos para a prevenção de uma infecção, métodos para a redução da atividade biológica de uma infecção e uso de um composto |
| DK3236972T3 (en) | 2014-12-26 | 2021-10-04 | Univ Emory | Antivirale N4-hydroxycytidin-derivativer |
| JP6804790B1 (ja) | 2017-12-07 | 2020-12-23 | エモリー ユニバーシティー | Ｎ４−ヒドロキシシチジンおよび誘導体ならびにそれらに関連する抗ウイルス用途 |
| WO2023152709A1 (en) * | 2022-02-14 | 2023-08-17 | Arbutus Biopharma Corporation | Rna polymerase inhibitors and methods using same |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE8802687D0 (sv) | 1988-07-20 | 1988-07-20 | Astra Ab | Nucleoside derivatives |
| EP0375183A1 (en) | 1988-12-05 | 1990-06-27 | Schering Corporation | Antiviral dimers and trimers |
| DK62592D0 (https=) * | 1992-05-14 | 1992-05-14 | Novo Nordisk As | |
| US5773424A (en) | 1994-12-16 | 1998-06-30 | Research Corporation Technologies, Inc. | Treatment of toxoplasmosis |
| EP0831852B1 (en) | 1995-06-07 | 2006-11-29 | Emory University | Nucleosides with anti-hepatitis b virus activity |
| ATE271063T1 (de) | 1996-10-16 | 2004-07-15 | Icn Pharmaceuticals | Purin-l-nukleoside, deren analoga und verwendungen |
| EP0948256A4 (en) | 1996-10-28 | 2007-10-24 | Univ Washington | INDUCTION OF VIRAL MUTATIONS BY INTRODUCTION TO ERROR-CODED RIBONUCLEOSIDE ANALOGUES IN VIRAL RNA |
| KR100719606B1 (ko) | 1998-02-25 | 2007-05-17 | 에모리 유니버시티 | 2'-플루오로뉴클레오사이드 |
| IL133680A0 (en) | 1999-09-10 | 2001-04-30 | Can Fite Technologies Ltd | Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist |
| AU2603101A (en) | 1999-12-22 | 2001-07-03 | Inspire Pharmaceuticals, Inc. | Method of treating gastrointestinal tract disease with purinergic receptor agonists |
-
2002
- 2002-07-30 US US10/207,005 patent/US7049303B2/en not_active Expired - Fee Related
- 2002-11-07 JP JP2003541742A patent/JP2005507944A/ja not_active Withdrawn
- 2002-11-07 EP EP02772630A patent/EP1441744A2/en not_active Withdrawn
- 2002-11-07 AU AU2002337388A patent/AU2002337388A1/en not_active Abandoned
- 2002-11-07 WO PCT/GB2002/005031 patent/WO2003039450A2/en not_active Ceased
-
2004
- 2004-05-07 US US10/840,238 patent/US20050043268A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2011139180A (ru) | Комбинация нуклеозидного ингибитора полимеразы и макроциклического ингибитора протеазы и ее применение для лечения гепатита с, фиброза печени и нарушенной печеночной функции | |
| CA2632626A1 (en) | Ester prodrugs of 2'-fluoro-2'-alkyl-2'-deoxycytidines and their use in the treatment of hcv infection | |
| JP2005507944A5 (https=) | ||
| JP2009535352A5 (https=) | ||
| EP0610444B1 (en) | Use of a polyhydroxybenzamide or a derivative thereof in the manufacture of a medicament for treating viral infectious diseases | |
| GB2613516A (en) | Formulations of anti-viral compounds | |
| KR20050044587A (ko) | Ｂ형 간염 바이러스 감염 치료용 포스포네이트뉴클레오타이드 유사체의 용도 | |
| WO2010031832A9 (en) | Synergistic combinations of a macrocyclic inhibitor of hcv and a thiophene-2-carboxylic acid derivative | |
| CA2373833A1 (en) | Medicinal compositions for preventing or treating viral myocarditis | |
| JP2018532797A5 (https=) | ||
| JPWO2023054732A5 (https=) | ||
| KR940010441B1 (ko) | B형감염의 항비루스제 | |
| US5039667A (en) | Antiviral therapy for hepatitis B with 2',3'-dideoxypurine nucleosides | |
| KR950701638A (ko) | 푸린 동족체의 항비루스성 포스폰산 유도체(Antiviral phosphonic acid derivatives of purine analogues) | |
| CN1943782A (zh) | 治疗禽流感感染 | |
| JP2002533470A5 (https=) | ||
| JPWO2020254985A5 (https=) | ||
| EP0137807A1 (en) | Antiviral composition and method for administering the same | |
| EP3600332B1 (en) | Hiv post-exposure prophylaxis | |
| JPWO2020205934A5 (https=) | ||
| HK1048951A1 (zh) | 与PEG-IFN-α结合的霉酚酸酯MOFETIL | |
| JPWO2020222108A5 (https=) | ||
| WO2000051615B1 (en) | Synergistic combinations of guanosine analog reverse transcriptase inhibitors and inosine monophosphate dehydrogenese inhibitors and uses therefor | |
| JPWO2023146974A5 (https=) | ||
| JPWO2021094563A5 (https=) |